Ryomoto Masaaki, Ishida Masaru, Ishizu Kanji, Funatsu Toshihiro
Department of Cardiovascular Surgery, Rinku General Medical Center, Osaka, Japan.
Ann Thorac Surg Short Rep. 2024 Jun 20;2(4):851-854. doi: 10.1016/j.atssr.2024.06.003. eCollection 2024 Dec.
The mortality rate of postcardiotomy cardiogenic shock after cardiovascular surgery is quite high, and the only way to avoid this serious complication is to initiate a preemptive strategy during surgery. The Impella 5.5 device with the SmartAssist system (Abiomed) is mainly used to prevent or to treat cardiogenic shock in cardiac surgery, but it is not often used in aortic surgery. We present the technique of preemptive insertion of the Impella 5.5 device through the ascending aorta intraoperatively to prevent the onset of postcardiotomy cardiogenic shock after cardiac or aortic surgery.
心血管手术后心源性休克的死亡率相当高，而避免这种严重并发症的唯一方法是在手术期间启动预防性策略。配备SmartAssist系统的Impella 5.5装置（Abiomed公司）主要用于预防或治疗心脏手术中的心源性休克，但在主动脉手术中并不常用。我们介绍了术中通过升主动脉预防性植入Impella 5.5装置的技术，以预防心脏或主动脉手术后心源性休克的发生。
